Tag: Prescription Drugs
Americans Struggling With High Cost of Prescription Drugs
Adults younger than 65 years twice as likely to report not filling needed prescriptions due to cost versus seniors
Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma
Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma
Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
0.5-mg and 1-mg tablets may contain levels of N-nitroso-varenicline at or above levels approved by the FDA
Predictors of Upper GI Bleeding Identified After Acute MI
UGIB after MI linked to increased risk for all-cause mortality and stroke, but not recurrent myocardial infarction; predictors of UGIB include age and smoking status
Antihypertensives Linked to Reduced Mortality in Colorectal Cancer
Reductions in mortality seen in association with ACE inhibitors, beta-blockers, thiazide diuretics
Monoclonal Antibody Therapy May Cut COVID-19 Hospitalizations
Lower hospitalization rates seen at 14, 21, 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab
Fixed-Dose Combination Therapies Reduce Cardiovascular Risk
Fixed-dose combo with BP-lowering meds, statin, and aspirin yields largest reduction in cardiovascular risk
2019 to 2020 Saw Increase in Benzodiazepine Overdose ED Visits
Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths
Ultra-Low-Dose Combo Cuts Systolic BP in Hypertension
Reduction in systolic blood pressure greater at week 12 with fixed-dose quadruple quarter-dose combo versus standard-dose monotherapy
Neurocognitive Effects of Ketamine for Depression Examined
Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression